Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Alyssa I. Clay, PhD, Theresa Hahn, PhD, Qianqian Zhu, PhD, Li Yan, PhD, Leah Preus, MS, Daniel O. Stram, PhD, Christopher A. Haiman, ScD, Loreall C. Pooler, MS, Xin Sheng, MS, Kenan Onel, MD PhD, Qian Liu, MA, Qiang Hu, PhD, Song Liu, PhD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 42.

https://doi.org/10.1182/blood.V128.22.42.42

Published: 2016

Journal Articles

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Binod Dhakal, MD MS, Tao Wang, PhD, Michael D Haagenson, MS, Fenlu Zhu, PhD, Carolyn A. Keever-Taylor, PhD, Stephen R. Spellman, MBS, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Stephanie J. Lee, MD, Wael Saber, MD MS

Blood (2016) 128 (22): 4678.

https://doi.org/10.1182/blood.V128.22.4678.4678

Published: 2016

Journal Articles

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Ezgi Karaesmen#, MS, Abbas Rizvi#, MS, Qianqian Zhu, PhD, Li Yan, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Song Liu, PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 71.

https://doi.org/10.1182/blood.V128.22.71.71

Published: 2016

Journal Articles

Feasibility of Allogeneic Hematopoietic Cell Transplantation Among High-Risk AML Patients in First Complete Remission: Results of the Transplant Objective from the SWOG (S1203) Randomized Phase III Study of Induction Therapy Using Standard 7+3 Therapy or Idarubicin with High-Dose Cytarabine (IA) Versus IA Plus Vorinostat

Blood (2016) 128 (22): 1166.

https://doi.org/10.1182/blood.V128.22.1166.1166

Published: 2016

Journal Articles

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Muna Qayed, MD MSc, John Horan, MD MPH, Stephen R. Spellman, MBS, Mukta Arora, MD, Tao Wang, PhD, Michael Hemmer, MS, Joseph A Pidala, MD, PhD, Daniel Couriel, MD MS, Amin M. Alousi, MD

Blood (2016) 128 (22): 2228.

https://doi.org/10.1182/blood.V128.22.2228.2228

Published: 2016

Journal Articles

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Shahinaz M. Gadalla, MD PhD MSC, Tao Wang, PhD, David Loftus, MD, Lyssa Friedman, RN, OCN, Casey Dagnall, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Ljubomir Buturovic, PhD, Marsha Blauwkamp, PhD, Jason Shelton, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Belynda Hicks, Kristine Jones, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 520.

https://doi.org/10.1182/blood.V128.22.520.520

Published: 2016

Journal Articles

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Qianqian Zhu#, PhD, Li Yan#, PhD, Qian Liu, MA, Qiang Hu, PhD, Leah Preus, MS, Alyssa I. Clay, PhD, Kenan Onel, MD PhD, Daniel O. Stram, PhD, Loreall C. Pooler, MS, Xin Sheng, MS, Christopher A. Haiman, ScD, Xiaochun Zhu, MS, Stephen R. Spellman, MBS, Marcelo C. Pasquini, MD, Philip L. McCarthy, MD, Song Liu, PhD, Theresa Hahn, PhD, Lara E. Sucheston-Campbell, PhD

Blood (2016) 128 (22): 518.

https://doi.org/10.1182/blood.V128.22.518.518

Published: 2016

Journal Articles

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

R. Coleman Lindsley, MD PhD, Wael Saber, MD MS, Brenton G. Mar, MD PhD, Robert A Redd, MS, Michael D Haagenson, MS, Peter V Grauman, BS, Stephen R. Spellman, MBS, Stephanie J. Lee, MD, Tao Wang, PhD, Michael R. Verneris, MD, Katharine C. Hsu, MD PhD, Katharina Fleischhauer, MD, Corey S. Cutler, MD MPH, Joseph H. Antin, MD, Donna S. Neuberg, ScD, Benjamin L. Ebert, MD PhD

Blood (2016) 128 (22): 69.

https://doi.org/10.1182/blood.V128.22.69.69

Published: 2016

Journal Articles

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

Shahinaz M. Gadalla, MD PhD MSC, Bari J Ballew, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Belynda Hicks, Blanche P Alter, MD MPH, Bin Zhu, PhD, Weiyin Zhou, MS, Meredith Yeager, PhD, Tao Wang, PhD, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Neal Freedman, PhD MPH, Stephanie J. Lee, MD, Sharon A Savage, MD FAAP

Blood (2016) 128 (22): 68.

https://doi.org/10.1182/blood.V128.22.68.68

Published: 2016

Journal Articles

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Blood (2015) 126 (23): 2621.

https://doi.org/10.1182/blood.V126.23.2621.2621

Published: 2015

Journal Articles

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 61.

https://doi.org/10.1182/blood.V126.23.61.61

Published: 2015

Journal Articles

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Blood (2015) 126 (23): 397.

https://doi.org/10.1182/blood.V126.23.397.397

Published: 2015

Journal Articles

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

Abeer Madbouly, PhD, Tao Wang, PhD, Mark Albrecht, MSTAT, MBA, Vanja Paunic, PhD, Michael D Haagenson, MS, Cynthia Vierra-Green, Katharina Fleischhauer, MD, Katharine C. Hsu, MD PhD, Michael R. Verneris, MD, Navneet S. Majhail, MD MS, Stephanie J. Lee, MD MPH, Stephen R. Spellman, MBS, Martin Maiers, MS

Blood (2015) 126 (23): 3229.

https://doi.org/10.1182/blood.V126.23.3229.3229

Published: 2015

Journal Articles

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Julia Pingel, PhD, Camila J. Hernandez Frederick, PhD, Tao Wang, PhD, Emmanuelle Polge, Michael D Haagenson, MS, Stephanie J. Lee, MD MPH, Mohamad Mohty, MD PhD, Arnon Nagler, MD MSc, Stephen R. Spellman, MBS, Alexander H. Schmidt, MD PhD, Jon J. van Rood, MD PhD

Blood (2015) 126 (23): 3226.

https://doi.org/10.1182/blood.V126.23.3226.3226

Published: 2015

Journal Articles

Outcomes of Grades II-IV Acute Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: How Much Progress Was Achieved?

Hanna Jean Khoury, MD, Tao Wang, PhD, Mukta Arora, MD, Michael Hemmer, MS, Stephen R. Spellman, MBS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Joseph A. Joseph, MD

Blood (2015) 126 (23): 3132.

https://doi.org/10.1182/blood.V126.23.3132.3132

Published: 2015

Journal Articles

Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value When Present in Isolation or in Addition to Grade I or Other Grade II-Defining GvHD Manifestations

Sarah Nikiforow, MD PhD, Michael Hemmer, MS, Stephen R. Spellman, MBS, Amin M. Alousi, MD, Daniel R. Couriel, MD, Joseph A Pidala, MD, PhD, Mukta Arora, MD, Corey S Cutler, MD MPH, Tao Wang, PhD

Blood (2015) 126 (23): 857.

https://doi.org/10.1182/blood.V126.23.857.857

Published: 2015

Journal Articles

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Veronika Bachanova, MD, Daniel J. Weisdorf, MD, Tao Wang, PhD, Steven G.E. Marsh, PhD, Elizabeth Trachtenberg, PhD, Michael D Haagenson, MS, Stephen R. Spellman, MBS, Guethlein A. Lisbeth, PhD, Martha Ladner, PhD, Peter Parham, PhD, Jeffrey S. Miller, MD, Sarah A. Cooley, MD MS

Blood (2014) 124 (21): 670.

https://doi.org/10.1182/blood.V124.21.670.670

Published: 2014

Journal Articles

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Andrew S. Artz, MD MS, Brent R. Logan, PhD, Xiaochun Zhu, MS, Görgün Akpek, MD MHS, Rodrigo Martino, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Alison Wakoff Loren, MD MS, Navneet S. Majhail, MD MS, Richard T. Maziarz, MD, Philip L. McCarthy, MD, Uday R. Popat, MD, Wael Saber, MD MS, Stephen R. Spellman, MBS, Olle Ringdén, MDPhD, Kenneth R. Cooke, MD, Marcelo C. Pasquini, MD MS

Blood (2014) 124 (21): 422.

https://doi.org/10.1182/blood.V124.21.422.422

Published: 2014

Journal Articles

Is There Any Effect of Killer Cell Immunoglobulin-like Receptor (KIR) on Outcomes after Single Unrelated Cord Blood Transplantation?

Vanderson Rocha, MD, Annalisa Ruggeri, MD PhD, Stephen R. Spellman, MBS, Tao Wang, PhD, Medhat Askar, MD PhD, Ron Sobecks, MD, Eliane Gluckman, MD, Mary Eapen, MBBS

Blood (2014) 124 (21): 48.

https://doi.org/10.1182/blood.V124.21.48.48

Published: 2014

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

NARROW

Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population

Pilot Study of Prognostic Impact of Pre-Allogeneic Hematopoietic Cell Transplantation (HCT) Plasma Levels of CXC-Chemokines (CXCL-4 and CXCL-7) in Patients with Myelodysplastic Syndromes (MDS)

Replication of Candidate SNP Survival Analyses and Gene-Based Tests of Association with Survival Outcomes after an Unrelated Donor Blood or Marrow Transplant: Results from the Discovery-BMT Study

Influence of Age on Risk for Acute and Chronic Graft Versus Host Disease in Children Receiving HLA Identical Sibling Bone Marrow Transplantation

Donor Telomere Length and Outcomes after Allogeneic Unrelated Hematopoietic Cell Transplant in Patients with Acute Leukemia

Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation

Genetic Alterations Predict Outcomes in Patients with Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Germline Mutations in Patients Receiving Unrelated Donor Hematopoietic Cell Transplant for Severe Aplastic Anemia

Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT)

Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study)

Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study)

Investigating Effect of Genetic Admixture and Donor/Recipient Genetic Disparity on Transplant Outcomes

Evaluation of the Impact of Non-Inherited Maternal Antigens on the Outcome of HLA Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation for Hematological Malignancies on Behalf of the ALWP of the EBMT and the CIBMTR

Outcomes of Grades II-IV Acute Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation: How Much Progress Was Achieved?

Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value When Present in Isolation or in Addition to Grade I or Other Grade II-Defining GvHD Manifestations

Unrelated Donor KIR B/X Genotype Reduces Relapse and Improves Progression-Free Survival after HLA-Matched Allogeneic Transplantation for Relapsed/Refractory Non-Hodgkin Lymphoma

Pre-Transplant C-Reactive Protein (CRP), Ferritin and Albumin As Biomarkers to Predict Transplant Related Mortality (TRM) after Allogeneic Hematopoietic Cell Transplant (HCT)

Is There Any Effect of Killer Cell Immunoglobulin-like Receptor (KIR) on Outcomes after Single Unrelated Cord Blood Transplantation?

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only